EUVIMEDEUVIMED entdecken
Crossref

Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway

Xin Jiao, Yuxin Zhang, Zengguang Wang, Hanwen Chang, Yongjin Li, Binbin Wang, Yaokai Gan, Dongyun Gu iD

Molecular Nutrition & Food Research · 2025

DOI: 10.1002/mnfr.70000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Xin Jiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University Sch…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Muscular Atrophy, Dexamethasone, Chalcones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Clinical Research Program of the 9th People's Hospital, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Muscle atrophy is a pathological condition characterized by the excessive degradation of muscle proteins, leading to impaired physical performance. Isoliquiritigenin (ISL) is a promising extract known for its medical effects; however, its impact on muscle atrophy remains unclear. We investigated the effects of ISL on muscle atrophy both in vitro and in vivo. The results showed that 5‐µM ISL exhibited no significant cytotoxicity on C2C12 cells, as reflected by cell count kit‐8 and 5‐ethynyl‐2′‐deoxyuridine (EdU) tests. ISL increased the diameter of myotubes and downregulated forkhead box O proteins, muscle‐specific RING finger protein 1 (MuRF‐1), and Atrogin‐1 induced by Dexamethasone (Dex). ISL could also enhance the phosphorylation of Akt, the mammalian target of rapamycin (mTOR), eIF4E‐binding protein 1, and p70 S6 kinase in C2C12 myotubes. In animal experiments, ISL increased the muscle mass, improved the cross‐sectional area of muscles, and inhibited the expression of MuRF‐1 and Atrogin‐1 in muscle tissues. For physical performance, ISL enhanced grip strength and running endurance. ISL ameliorated Dex‐induced muscle atrophy both in vitro and in vivo, associated with increased diameter of myotubes and decreased Atrogin‐1 and MuRF‐1 expression via the Akt/mTOR signaling pathway. This suggested that ISL could be used as a natural drug for muscle atrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesMuscular AtrophyDexamethasoneChalconesProto-Oncogene Proteins c-aktGlycyrrhizaPlant ExtractsAnimalsMiceMuscle ProteinsMuscle Fibers, SkeletalUbiquitin-Protein LigasesCell LineMaleSKP Cullin F-Box Protein LigasesSignal TransductionTripartite Motif ProteinsMice, Inbred C57BLMuscle, SkeletalPhosphorylationCell Cycle ProteinsAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

AktC2C12isoliquiritigeninmTORmuscle atrophy

Substanzen

TOR Serine-Threonine KinasesDexamethasoneChalconesProto-Oncogene Proteins c-aktisoliquiritigeninmTOR protein, mouseMuscle ProteinsUbiquitin-Protein LigasesSKP Cullin F-Box Protein LigasesTripartite Motif Proteins

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.
  • Engineering Research Center of Digital Medicine and Clinical Translation, Ministry of Education, Shanghai, China.
  • Department of Oral Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • National Center for Stomatology, Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.
  • National Clinical Research Center for Oral Diseases, Research Unit of Oral and Maxillofacial Regenerative Medicine, Chinese Academy of Medical Sciences, Shanghai, China.

ORCID-Profile: Dongyun Gu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Clinical Research Program of the 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
  • Shanghai Key Laboratory of Orthopedic Implants

Zitieren

APA

Jiao, X., Zhang, Y., Wang, Z., Chang, H., Li, Y., Wang, B., Gan, Y., & Gu, D. (2025). Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70000

Vancouver

Jiao X, Zhang Y, Wang Z, Chang H, Li Y, Wang B, et al. Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70000

BibTeX
@article{Jiao2025,
  author = {Jiao, Xin and Zhang, Yuxin and Wang, Zengguang and Chang, Hanwen and Li, Yongjin and Wang, Binbin and Gan, Yaokai and Gu, Dongyun},
  title = {Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway},
  journal = {Molecular Nutrition & Food Research},
  year = {2025},
  doi = {10.1002/mnfr.70000}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche